These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3570744)

  • 1. Application of competition kinetics to investigate rat brain muscarinic receptors.
    Schreiber G; Henis YI; Sokolovsky M
    Isr J Med Sci; 1987; 23(1-2):36-43. PubMed ID: 3570744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate constants of agonist binding to muscarinic receptors in rat brain medulla. Evaluation by competition kinetics.
    Schreiber G; Henis YI; Sokolovsky M
    J Biol Chem; 1985 Jul; 260(15):8795-802. PubMed ID: 4019454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic antagonists induce different receptor conformations in rat adenohypophysis.
    Henis YI; Sokolovsky M
    Mol Pharmacol; 1983 Nov; 24(3):357-65. PubMed ID: 6633502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisquaternary pyridinium oximes as allosteric inhibitors of rat brain muscarinic receptors.
    Kloog Y; Sokolovsky M
    Mol Pharmacol; 1985 Apr; 27(4):418-28. PubMed ID: 3884998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
    Watson M; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.
    Ladner CJ; Lee JM
    Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The binding of agonists to brain muscarinic receptors.
    Birdsall NJ; Burgen AS; Hulme EC
    Mol Pharmacol; 1978 Sep; 14(5):723-36. PubMed ID: 714021
    [No Abstract]   [Full Text] [Related]  

  • 9. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart.
    Martin MW; Smith MM; Harden TK
    J Pharmacol Exp Ther; 1984 Aug; 230(2):424-30. PubMed ID: 6379149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
    Ehlert FJ; Jenden DJ
    Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR; Wolfe BB
    Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective binding and activity of oxotremorine analogs at muscarinic receptors in rat brain.
    Messer WS; Ngur DO; Abuh YF; Dokas LA; Ting SM; Hacksell U; Nilsson BM; Dunbar PG; Hoss W
    Chirality; 1992; 4(8):463-8. PubMed ID: 1476855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites.
    Waelbroeck M; Robberecht P; Chatelain P; Christophe J
    Mol Pharmacol; 1982 May; 21(3):581-8. PubMed ID: 7110116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane.
    Vickroy TW; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1984 Jun; 229(3):747-55. PubMed ID: 6202869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of muscarinic acetylcholine receptors from mouse brain: evidence for regional heterogeneity and isomerization.
    Kloog Y; Egozi Y; Sokolovsky M
    Mol Pharmacol; 1979 May; 15(3):545-58. PubMed ID: 492145
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo regulation of muscarinic cholinergic receptors in embryonic chick brain.
    Meyer MR; Gainer MW; Nathanson NM
    Mol Pharmacol; 1982 Mar; 21(2):280-6. PubMed ID: 7099136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperativity pattern in the interaction of the antiestrogen drug clomiphene with the Muscarinic receptors.
    Ben-Baruch G; Schreiber G; Sokolovsky M
    Mol Pharmacol; 1982 Mar; 21(2):287-93. PubMed ID: 7099137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High affinity binding of [3H]acetylcholine to muscarinic receptors. Regional distribution and modulation by guanine nucleotides.
    Gurwitz D; Kloog Y; Sokolovsky M
    Mol Pharmacol; 1985 Sep; 28(3):297-305. PubMed ID: 4033630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.